Elite Pharms Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2021 | 03-2020 | 03-2019 | 03-2018 | 03-2017 | |
| Sales | 25,381 | 17,995 | 7,569 | 7,459 | 9,638 |
| Cost of Goods | 13,514 | 10,016 | 4,701 | 3,511 | 5,898 |
| Gross Profit | 11,867 | 7,979 | 2,868 | 3,948 | 3,739 |
| Operating Expenses | 10,276 | 10,280 | 12,727 | 13,510 | 11,994 |
| Operating Income | 2,105 | -2,285 | -9,159 | -9,051 | -7,356 |
| Interest Expense | 260 | 356 | 369 | 336 | 238 |
| Other Income | 2,300 | 403 | -427 | 4,668 | 9,538 |
| Pre-tax Income | 4,145 | -2,238 | -9,955 | -4,719 | 1,944 |
| Income Tax | N/A | 2 | -676 | -1,046 | -1,868 |
| Net Income Continuous | 5,088 | -2,240 | -9,279 | -3,673 | 3,811 |
| Net Income | $5,088 | $-2,240 | $-9,279 | $-3,673 | $3,811 |
| EPS Basic Total Ops | 0.01 | 0.00 | -0.01 | 0.00 | 0.03 |
| EPS Basic Continuous Ops | 0.01 | 0.00 | -0.01 | 0.00 | 0.00 |
| EPS Diluted Total Ops | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | 0.01 | 0.00 | -0.01 | 0.00 | 0.00 |
| EPS Diluted Before Non-Recurring Items | 0.01 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $3,629 | $-775 | $-7,902 | $-8,055 | $-6,641 |